Cargando…
LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis
BACKGROUND: Cisplatin (DDP) is a major chemotherapeutic drug which was widely used for cervical cancer (CC) patients with advanced or recurrent although its limitation in the development of resistance. LncRNA nicotinamide nucleotide transhydrogenase-antisense RNA1 (NNT-AS1) has been reported to be i...
Autores principales: | Liu, Yanjie, Guo, Ruixia, Qiao, Yuhuan, Han, Liping, Liu, Mingzhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247171/ https://www.ncbi.nlm.nih.gov/pubmed/32489326 http://dx.doi.org/10.1186/s12935-020-01278-9 |
Ejemplares similares
-
Antisense lncRNA NNT-AS1 promoted esophageal squamous cell carcinoma progression by regulating its sense gene NNT expression
por: Pan, Xianglong, et al.
Publicado: (2022) -
NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis
por: Yao, Changlei, et al.
Publicado: (2020) -
LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis
por: Ma, Jing, et al.
Publicado: (2020) -
NNT in NSCLC: No need to worry?
por: Conrad, Marcus
Publicado: (2020) -
The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children
por: Chen, Ping, et al.
Publicado: (2021)